The FDA granted Viveve 510(k) clearance for its Viveve 2.0 system, a cryogen-cooled monopolar radiofrequency device used to rebuild natural collagen in female patients.

The device is used in general procedures for electrocoagulation and hemostasis, using controlled cooling to protect tissue from damage while allowing for greater penetration of its radio waves.

The system uses a small probe that emits cryogen-cooling and radio waves to spur the production of new collagen and tissue reinvigoration.